4
Changes in Ownership
Olema Oncology, Inc. Filed Acc 0001415889-24-012020
Director sold 15,000 shares at $9.51 ($142,650)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harmon Cyrus Director | 2024-04-30 | Sale 10b5-1 | −15,000 | $9.51 | $142,650 | 811,283 | D |
| Open-market sales · 15,000 sh · avg $9.51 · $142,650 | |||||||
Loading xslF345X05/form4-05022024_090504.xml…